| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| The absence of dystrophin leads to a dramatic reduction of the dystrophin associated proteins ( 156DAG , 59DAP , 50DAG , 43DAG and 35DAG ) in the sarcolemma of patients with Duchenne muscular dystrophy and mdx mice . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Antibodies against 50DAG ( A 2 ) and 43DAG ( A3a ) , the components of GPC , were used for the detection of GPC . ^^^ We found that , although the amount of GPC was reduced in DMD muscles where utrophin but not dystrophin was distinctly present , 43DAG ( A3a ) was fairly heavily and 50DAG ( A 2 ) was lightly but distinctly stained on the cell surfaces . ^^^ We also found that 43DAG ( A3a ) but not 50DAG ( A 2 ) was detected in the peripheral nerves where utrophin was detected . ^^^ Therefore , it is likely that 43DAG ( A3a ) is essential for the fixation of utrophin to cell membranes , as in the case of dystrophin . 50DAG ( A 2 ) may play other important roles in the pathogenesis of DMD . . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Distribution of dystrophin isoforms and dystrophin associated proteins 43DAG ( A3a ) and 50DAG ( A 2 ) in various monkey tissues . ^^^ To determine the distributions of two known dystrophin isoforms derived from the 3 ' part of the dystrophin gene and of the dystrophin associated proteins [ 50DAG ( A 2 ) and 43DAG ( A3a ) ] by immunoblot analysis , we examined various monkey tissues [ skeletal ( quadriceps ) , cardiac ( left ventricle ) , and smooth ( aorta and uterus ) muscles , lung , liver , central nervous system ( cerebrum , cerebellum , and spinal cord ) , and peripheral nerve ( sciatic nerve ) ] . ^^^ Dystrophin associated protein , 43DAG , was detected in all the tissues examined , but 50DAG was detected only in skeletal and cardiac muscles . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Antibodies against dystrophin , utrophin and DAGs including 50DAG ( A 2 ) , 43DAG ( A3a ) and 35DAG ( A 4 ) were employed for the examination . ^^^ On the other hand , in the dystrophic hamster 50DAG ( A 2 ) and 35DAG ( A 4 ) were selectively defective , and 43DAG ( A3a ) was also decreased , although to a lesser degree . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| This distribution pattern is the same as that of 50DAG but different from that of 43DAG ( A3a ) [ Mizuno et al . ( 1993 ) J . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| We recently reported that the dystrophin associated glycoprotein ( DAG ) complex is biochemically divided into two subcomplexes : one is the dystroglycan complex comprised of 156DAG and 43DAG and the other is the sarcoglycan complex comprised of 50DAG , A3b , and 35DAG . ^^^ In the present study , we examined the striated muscles of the dystrophic hamster with anti A3b antibody in addition to anti 50DAG , anti 43DAG , anti 35DAG , anti dystrophin , and anti laminin antibodies by both immunohistochemistry and immunoblot analysis and found that 50DAG , A3b , and 35DAG are selectively lost . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| In particular , we found that the glycoprotein complex stated above was dissociated into two distinct groups : one composed of 156DAG and 43DAG ( A3a ) and the other composed of 50DAG , 35DAG and A3b . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Dystrophin associated glycoprotein complex is classified into two subcomplexes : the dystroglycan complex ( 156DAG and 43DAG ) and the sarcoglycan complex ( 50DAG , A3b , and 35DAG ) . ^^^ We examined muscles from five SCARMD patients and found that dystrophin and 43DAG were present in almost normal levels while 35DAG and the newly identified protein A3b in addition to 50DAG were absent or greatly reduced . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Adhalin ( 50 kDa dystrophin associated glycoprotein ) and beta dystroglycan ( 43 kDa dystrophin associated glycoprotein ) are the transmembrane components of the normal muscle plasma membrane , and beta dystroglycan has been demonstrated to bind dystrophin at the inside surface of normal muscle plasma membrane . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| The dystrophin associated proteins are classified into three groups : ( 1 ) alpha and beta dystroglycan , ( 2 ) adhalin , 35DAG and A3b , and ( 3 ) members of the syntrophin family . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Screening for sarcoglycan gene mutations in 50 of the 54 patients revealed mutations in 29 patients ( 58 percent ) : 17 ( 34 percent ) had mutations in the alpha sarcoglycan gene , 8 ( 16 percent ) in the beta sarcoglycan gene , and 4 ( 8 percent ) in the gamma sarcoglycan gene . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| We have investigated the expression , using immunohistochemistry , of beta and gamma sarcoglycans in the muscles of 20 patients in whom previous screening had revealed a deficiency of alpha sarcoglycan . alpha , beta and gamma sarcoglycans were absent in 7 patients and variably reduced in 8 patients , in 2 of whom beta sarcoglycan was more reduced than the alpha and gamma proteins . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Dystrophin associated proteins are comprised of an extracellular glycoprotein of 156 kDa ( 156DAG ) , transmembrane glycoproteins of 50 kDa ( 50DAG ) , 43 kDa ( 43DAG ) and 35 kDa ( 35DAG ) , and a cytoskeletal protein of 59 kDa ( 59DAP ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| The frequency of patients with 50 kd dystrophin associated glycoprotein ( 50DAG or adhalin ) deficiency in a muscular dystrophy patient population in Japan : immunocytochemical analysis of 50DAG , 43DAG , dystrophin , and utrophin . ^^^ To elucidate the frequency of patients having the 50DAG deficiency in a muscular dystrophy population in Japan , we immunocytochemically examined 50DAG , 43DAG , dystrophin , and utrophin . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| To evaluate a potential regulatory role of the nerve , the distribution and expression of dystrophin , of beta dystroglycan ( 43DAG ) and adhalin ( 50DAG ) , two of the dystrophin associated proteins and utrophin ( dystrophin related protein or DRP ) were studied in rat muscles after 2 weeks of denervation . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Pathogenetic mutations involving one gene for sarcoglycan complex components were identified in 13 patients : alpha sarcoglycan in seven , beta sarcoglycan in two , gamma sarcoglycan in four , and none in the delta sarcoglycan gene . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Transcripts of alpha sarcoglycan ( SGCA ) were visible as soon as myotomes were formed , and constitute , together with titin transcripts , precocious muscular system landmarks . beta sarcoglycan ( SGCB ) was initially transcribed in a ubiquitous manner , and , toward the second part of the embryonic period , became specific to striated muscle , heart , and the central nervous system . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| We investigated the expression of alpha sarcoglycan , beta sarcoglycan , gamma sarcoglycan , and delta sarcoglycan immunohistochemically in three patients with mutations of the alpha sarcoglycan gene and a patient with a mutation of the gamma sarcoglycan gene . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| The classification of families was as follows : calpainopathy 7 , dysferlinopathy 3 , alpha sarcoglycan deficiency 2 , beta sarcoglycan deficiency 7 , gamma sarcoglycan deficiency 5 , delta sarcoglycan deficiency 1 , and merosinopathy 2 . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| However , comparison of persistence of expression in 51 injected mice showed substantial differences between AAV alpha sarcoglycan ( alpha SG ) and beta sarcoglycan ( beta SG ) vectors . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| They are : calpain 3 ( LGMD2A ) , dysferlin ( LGMD2B ) , alpha sarcoglycan ( LGMD2D ) , beta sarcoglycan ( LGMD2E ) , gamma sarcoglycan ( LGMD2C ) , delta sarcoglycan ( LGMD2F ) , telethonin ( LGMD2G ) , TRIM 32 ( LGMD2H ) , fukutin related protein ( LGMD2I ) and titin ( LGMD2J ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Immunohistochemical staining demonstrated alpha sarcoglycan and beta sarcoglycan expression on the basement membrane of the cardiomyocytes in the S group but not in the other groups . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Sarcoglycanopathies are a genetically heterogeneous group of autosomal recessive muscular dystrophies in which the primary defect may reside in any of the genes coding for the different partners of the sarcolemmal sarcoglycan ( SG ) complex : the alpha SG ( LGMD2D at 17q21 . 2 ) , the beta SG ( LGMD2E at 4q12 ) , the gamma SG ( LGMD2C at 13q12 ) , and the delta SG ( LGMD2F at 5q33 ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Five genes have already been identified : calpain 3 at LGMD2A ( 15q15 ) , and four members of the sarcoglycan ( SG ) complex , alpha SG at LGMD2D ( 17q21 ) , beta SG at LGMD2E ( 4q12 ) , gamma SG at LGMD2C ( 13q12 ) , and delta SG at LGMD2F ( 5q33 q 34 ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Eight genes are mapped for the AR LGMDs ; they are : LGMD2A ( CAPN 3 ) at 15q , LGMD2B ( dysferlin ) at 2p , LGMD2C ( gamma SG ) at 13q , LGMD2D ( alpha SG ) at 17q , LGMD2E ( beta SG ) at 4q , LGMD2F ( 6 SG ) at 5q , LGMD2G at 17q , and more recently LGMD2H at 9q . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Sarcoglycanopathies ( SGPs ) constitute a subgroup of limb girdle muscular dystrophies ( LGMD ) , where the primary defect in one sarcoglycan ( SG ) glycoprotein ( alpha SG , beta SG , gamma SG or delta SG ) results in a deficiency of the whole complex . ^^^ DNA analysis for the four sarcoglycan genes showed that alpha SG mutations accounted for 47 % , beta SG for 16 % , gamma SG for 16 % and delta SG for 21 % of the cases . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| The SG complex consists of four transmembrane glycoproteins , alpha SG , beta SG , gamma SG and delta SG . ^^^ We found that beta SG and delta SG were co expressed with epsilon SG , a alpha SG homolog , in the peripheral nerve , but not with alpha SG or gamma SG . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| A subgroup among the autosomal recessive forms comprises the sarcoglycanopathies ( LGMD2C 2F ) , caused by mutations in the gamma ( gamma SG ) , alpha ( alpha SG ) , beta ( beta SG ) and delta ( delta SG ) sarcoglycan genes , respectively . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| The alpha SG was normal in 42 patients , beta SG in 28 , beta SG in 45 , deltaSG in 32 , dysferlin in 37 and calpain 3 in 9 . ^^^ There was a reduction in the alpha SG in 7 patients , beta SG in 4 , gamma SG in 2 , and delta SG in 8 . ^^^ There was deficiency of alpha SG in 7 patients , beta SG in 6 , gamma SG in 9 , delta SG in 5 , dysferlin in 8 , and calpain 3 in 5 . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Immunoprecipitation analysis showed that zeta SG or gamma SG formed a SGC with beta SG and delta SG plus alpha SG or epsilon SG , revealing that zeta SG can form two types of SGCs ( alpha beta zeta delta or epsilon beta zeta delta ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| An autosomal dominant form ( LGMD1A ) has been mapped at 5q22 . 3 31 . 3 , while five genes responsible for the autosomal recessive forms were mapped respectively at : 15q15 . 1 ( LGMD2A ) , 2p12 p 16 ( LGMD2B ) , 13q12 ( LGMD2C ) , 17q12 q21 . 33 ( LGMD2D ) and 4q12 ( LGMD2E ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| One autosomal dominant ( LGMD1A , at chromosome 5q22 . 3 31 . 3 ) ( ref . 3 ) and five autosomal recessive ( AR ) loci responsible for this phenotype have been identified : LGMD2A at 15q ( ref . 4 ) ; LGMD2B at 2p ( ref . 5 ) , LGMD2C at 13q ( ref . 6 ) , LGMD2D at 17q ( ref . 7 ) and LGMD2E at 4q ( refs 8 , 9 ) . ^^^ The genes for LGMD2C , LGMD2D and LGMD2E code for proteins of the SG complex . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Recently six different loci for LGMD have been reported : 5q ( LGMD1A ) , 15q ( LGMD2A ) , 2p ( LGMD2B ) , 13q ( LGMD2C ) , 17q ( LGMD2D ) and 4p 14 q21 . 2 ( LGMD2E ) respectively . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Immunohistochemical analysis of skeletal muscle biopsies from patients with LGMD2C , LGMD2D , and LGMD2E demonstrated a reduction of the entire sarcoglycan complex in these muscular dystrophies . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| This clinical heterogeneity has been demonstrated at the molecular level , since the genes for six AR forms have been cloned and / or have been mapped to 15q15 . 1 ( LGMD2A ) , 2p12 16 ( LGMD2B ) , 13q12 ( LGMD2C ) , 17q12 q21 . 33 ( LGMD2D ) , 4q12 ( LGMD2E ) , and 5q33 34 ( LGMD2F ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| The marker loci were genotyped in 96 LGMD 2 families leading to genetic definition of 25 of them either with a high likelihood or with a suggested localization ( 7 LGMD2A , 5 LGMD2B , 4 LGMD2C , 4 LGMD2D , 2 LGMD2E and 3 LGMD2F ) . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| LGMD2C , LGMD2D , LGMD2E , LGMD2F ] . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| We used two complementary approaches , namely immunolocalization of SGC alpha subunit ( SGCalpha ) , and of cyclic GMP ( cGMP ) after exposure to an NO donor . ^^^ NO donors induced a pattern of cGMP immunostaining that was similar to the distribution of SGCalpha , indicating that both sensory and motor neurons contain functional SGC . ^^^ Although the expression of SGCalpha was highly consistent , NO donors did not always induce cGMP staining in SGC containing neurons , suggesting that SGC is coregulated by factors other than NO . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Here , sGC was analyzed in rat brain by Western blot and NO donor stimulated cyclic GMP accumulation . sGCalpha ( 1 ) and sGCbeta ( 1 ) immunoreactive protein signals strongly correlated with each other . ^^^ In conclusion , we show that expression of both sGCalpha ( 1 ) and sGCbeta ( 1 ) subunits is tightly coregulated in rat brain , while yet unknown additional mechanisms affect the 5 ( max ) of sGC . . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| In this study , we examined the expression of the NO signaling pathway components nitric oxide synthase ( NOS 1 , 2 , 3 ) , soluble guanylyl cyclase ( sGCalpha ( 1 ) and beta ( 1 ) ) and protein kinase G ( PKG ) genes and sGC activity in murine ES cells subjected to differentiation by embryoid body ( EB ) formation . ^^^ Purification of ES cell derived CM revealed that mRNA expression of all the NOS isoforms was very low to absent while sGCalpha ( 1 ) and beta ( 1 ) subunit mRNAs were abundant and sGC mediated cGMP production was apparent in this population of cells . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| DNA sequence analysis of two regions of the cloned gene cluster revealed two genes , sgcA and sgcB , that encode an NGDH enzyme and a transmembrane efflux protein , respectively , and confirmed that the cagA gene resides approximately 14 kb upstream of the sgcAB locus . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| We have designed Multiplex Amplifiable Probe Hybridization ( MAPH ) probes for 28 exons of the sarcoglycan genes SGCA , SGCB , SGCG , and SGCD . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| To get a closer view on the differentiating molecular events responsible for the muscular dystrophies , we have carried out a comparative gene expression profiling of hindlimb muscles of the following mouse models : dystrophin deficient ( mdx , mdx ( 3cv ) ) , sarcoglycan deficient ( Sgca null , Sgcb null , Sgcg null , Sgcd null ) , dysferlin deficient ( Dysf null , SJL ( Dysf ) ) , sarcospan deficient ( Sspn null ) , and wild type ( C57Bl / 6 , C57Bl / 10 ) mice . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| Mutations in SGCA , SGCB , SGCG and SGCD genes are associated with LGMD 2D , 2E , 2C and 2F , respectively . ^^^ |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q16585 and Q16586 |
Pubmed |
SVM Score :0.0 |
| NA |
|